Receptor tyrosine kinase inhibition leads to regression of acral melanoma by targeting the tumor microenvironment -н Smith, EA, Belote, RL, Cruz, NM, Moustafa, TE, Becker, CA, Jiang, A, Alizada, S, Prokofyeva, A, Chan, TY, Seasor, TA, Balatico, M, Cortes-Sanchez, E, Lum, DH, Hyngstrom, JR, Zeng, H, Deacon, DC, Grossmann, AH, White, RM, Zangle, TA, Judson-Torres, RL